Fundraising FoxOrigami Surgical
Madison, US · Founded 2020 · Delaware corporation
Find your way into Origami Surgical
Sign up to see every warm intro you have to Origami Surgical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Origami Surgical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Origami Surgical makes StitchKit, a product for robotic surgery that addresses exposed needle transfer to reduce lost sharps and near-miss sharps events. It targets surgical facilities and surgeons performing robotic procedures, aiming to improve patient safety and operating room efficiency.
Founders & leadership
JH
PC
Patrick CulliganNamed on SEC filing
SM
Sean McNerneyNamed on SEC filing
Board
Reported raises · per SEC filings
Form D private placements$6.8M disclosed across 5 rounds · 2020–2025
▶$450KraisedJul 2025 · 6 investors · OtherRule 506(b)
▶$450KraisedJul 2025 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Scott FloraDirector
- Marc BeerExecutive Officer, Director, Promoter
- Joseph L. LeeDirector
- Patrick Culligan, M.D.Executive Officer, Director, Promoter
- John HironimusExecutive Officer, Director
- Offering amount
- $1000K
- Amount sold
- $450K
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedNov 2024 · 6 investors · OtherRule 506(b)
▶$1.5MraisedNov 2024 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Patrick CulliganExecutive Officer, Director
- Marc BeerExecutive Officer, Director
- John HironimusExecutive Officer, Director
- Joseph LeeDirector
- Scott FloraDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.4MraisedDec 2023 · 6 investors · OtherRule 506(b)
▶$1.4MraisedDec 2023 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- John HironimusExecutive Officer, Director
- Patrick CulliganExecutive Officer, Director
- Marc BeerExecutive Officer, Director
- Joseph L. LeeDirector
- Scott FloraDirector
- Offering amount
- $2.1M
- Amount sold
- $1.4M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.3MraisedJul 2022 · 3 investors · OtherRule 506(b)
▶$1.3MraisedJul 2022 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Marc BeerExecutive Officer, Director
- Sean McNerneyExecutive Officer, Director
- Joseph LeeDirector
- Patrick CulliganExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.2MraisedApr 2020 · 2 investors · OtherRule 506(b)
▶$2.2MraisedApr 2020 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Marc BeerExecutive Officer, Director
- Patrick CulliganExecutive Officer, Director
- Joseph LeeDirector
- Sean McNerneyExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.2M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Origami Therapeutics, Inc.Origami Therapeutics is a preclinical-stage biopharmaceutical company developing protein degrader therapeutics to treat neurodegenerative diseases, starting with Huntington's disease. The company uses a proprietary platform that harnesses the body's natural protein disposal system to degrade disease-causing proteins.
Companies working in the same space as Origami Surgical.
Frequently asked questions
- What does Origami Surgical do?
- Origami Surgical makes StitchKit, a product for robotic surgery that addresses exposed needle transfer to reduce lost sharps and near-miss sharps events. It targets surgical facilities and surgeons performing robotic procedures, aiming to improve patient safety and operating room efficiency.
- How much funding has Origami Surgical raised?
- Origami Surgical has disclosed $6.8M raised across 5 rounds.
- Where is Origami Surgical headquartered?
- Origami Surgical is headquartered in Madison, US.